2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappa B suppression (Retraction of Vol 32, Pg 154, 2011)-论文-万方医学网

首页> > 2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappa B suppression (Retraction of Vol 32, Pg 154, 2011)

2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappa B suppression (Retraction of Vol 32, Pg 154, 2011)

导出原文传递

翻译打印收藏纠错

第一作者： Lin, Tingting

作者： Lin, Tingting ; Ding, Zhiying ; Li, Nan ; Xu, Jiayun ; Luo, Guimin ; Liu, Junqiu ; Shen, Jiacong

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappa B suppression (Retraction of Vol 32, Pg 154, 2011)

相似文献

同项目论文

相关期刊

检索历史 清除

2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappa B suppression (Retraction of Vol 32, Pg 154, 2011)

相似文献

同项目论文

相关期刊

检索历史清除